The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Endometriosis and aspirin: a systematic review
Open accessAbstract
Introduction: Endometriosis is delineated as a benign yet steroid-dependent disorder characterized by the ectopic presence of endometrial glandular and stromal cells outside the uterine cavity, affecting estimated 10%–15% of women of reproductive age, 20%–50% of all women with infertility and costing a great economic burden per-patient. Endometriosis exerts pervasive influence on multiple facets of female reproductive physiology. Given its characterization as a chronic inflammatory disorder, escalated levels of pro-inflammatory cytokines were unequivocally recognized as well-established characteristics of endometriosis, which might attribute to mechanisms like retrograde menstruation, progesterone receptor resistance, and immune dysregulation. Therapeutic utilization of non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin, analgesic agent for reducing pain, inflammation, and fever, could be holding promise in augmenting reproductive outcomes of endometriosis women. Therefore, the objective of this comprehensive review is to elucidate the intricate interplay between endometriosis and aspirin, both within the context of infertility and beyond. We meticulously explore potential pharmacological agents targeting endometriosis, which may concurrently optimize the efficacy of reproductive interventions, while also delving into the underlying mechanistic pathways linking endometriosis with inflammatory processes. Methods: We conducted a comprehensive search in the data available in PubMed and the Web of Science using the terms ‘endometriosis’ and ‘aspirin’. Then analyzed the identified articles based on established inclusion and exclusion criteria independently by three reviewers. Results: The survey of the chosen terms revealed 72 articles, only 10 of which were considered for review. Discussion: Based on the research available currently, it is not substantial enough to address the conclusion that aspirin shall be an effective therapeutic choice for endometriosis, further studies are needed to elucidate the efficacy, safety profile, and optimal dosing regimens of aspirin in the context of endometriosis treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“with some evidence suggesting that endometriosis may have a prothrombotic component [43].”
From Endometriosis and Cardiovascular Disease: Exploring Pathophysiological Interconnections and Risk Mechanisms (2025) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these, antiplatelet agents, beta-blockers, statins, and metformin have shown promise.”
From Endometriosis and Cardiovascular Disease: Exploring Pathophysiological Interconnections and Risk Mechanisms (2025) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antiplatelet drugs, such as aspirin, may help reduce inflammation and limit the progression of endometrial lesions by inhibiting platelet aggregation and thromboxane production”
From Endometriosis and Cardiovascular Disease: Exploring Pathophysiological Interconnections and Risk Mechanisms (2025) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Sampson, J. A. (1927) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30003-x · Cited by 2,334
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
Giudice, L. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1000274 · Cited by 1,924
Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations
Taylor, H. S., Kotlyar, A. M., & Flores, V. A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00389-5 · Cited by 1,425
Rethinking mechanisms, diagnosis and management of endometriosis
Chapron, C., Marcellin, L., Borghese, B., & Santulli, P. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0245-z · Cited by 1,084 · cited 1×
“Notably, the ectopic proliferation of endometrial tissue within the ovaries, either unilaterally or bilaterally, culminating in the formation of cystic masses referred to as OMA, predominantly impairs women ’ s reproductive capabilities by disrupting oocyte formation and maturation (4).”
Background(1927) · PubMed Central · Cited by 1,008
Endometriosis: Etiology, pathobiology, and therapeutic prospects
Saunders, P. T. K., & Horne, A. W. (2021) · Cell · doi:10.1016/j.cell.2021.04.041 · Cited by 961
Kutteh, W. H. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70610-5 · Cited by 803
Research works printed but not linked: 1
- 2017, Endometriosis: diagnosis and management
Cited by
Szpila, G., Szczotka, J., Suchodolski, A., & Szulik, M. (2025) · Diagnostics · doi:10.3390/diagnostics15121458 · Cited by 7
“An-tiplatelet drugs, such as aspirin, may help reduce inflammation and limit the progression of endometrial lesions by inhibiting platelet aggregation and thromboxane production, with some evidence suggesting that endometriosis may have a prothrombotic component [43].”
Endometrial immune profile: A predictor of pregnancy success
Baharaghdam, S., Karimi, S., Farahani, M. E., Maleki, L. A., & Yousefi, M. (2025) · Reproductive Biology · doi:10.1016/j.repbio.2025.101174 · Cited by 6
EZH2 promotes endometriosis progression through estrogen receptor and TNFα expression
Liu, X., Cheng, L., Huang, L., Li, M., Shen, Q., Li, D., Dai, K., Fu, Y., Liu, Y., Yao, P., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1574938 · Cited by 1
Current Approaches to the Treatment of Endometriosis: A Narrative Review
Słowik, J., Mika, W., Sieradzka, I., Wajda, K., & Kostyniak, W. (2026) · Journal of Education Health and Sport · doi:10.12775/jehs.2026.87.67581 · Cited by 1
Rashidian, P., & Hantoushzadeh, S. (2025) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/22840265251343443
Metadata
- Authors
- Yang, Y., Lai, H., Li, Z., & Zhang, J.
- Affiliations
- Jinan University (CN)
- Peking University (CN)
- Corresponding author
- Zhang, Jun
- ORCID
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2024-08-27
- Volume
- 15
- Pages
- 1409469-1409469
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC11384985
- OpenAlex
- W4401930056
- Cited by
- 7
- References
- 58
- Citations by year
- 2026: 2 · 2025: 5
- FWCI
- 0.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Keywords
- endometriosis, aspirin, nonsteroidal anti-inflammatory drugs, infertility, chronic inflammation, inflammatory cytokines, immune dysregulation, retrograde menstruation, endometriosis treatment
- MeSH terms
- Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Endometriosis, Female, Humans, Infertility, Female
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endometriosis and aspirin: a systematic review. https://app.cochat.ai/papers/10.3389/fendo.2024.1409469
- The paper
- Yang, Y., Lai, H., Li, Z., & Zhang, J. (2024). Endometriosis and aspirin: a systematic review. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2024.1409469
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.